CLRB

Cellectar Biosciences, Inc.$3.02-0.09 (-2.83%)

Prev Close$3.18·MCap$8.8M·P/E—·Vol12.3K·Yield—

▲

Buys (12M)

$74.8K

▼

Sells (12M)

$731.99

◆

Net Activity

Net Buyer

$74.1K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Cellectar Biosciences, Inc. (CLRB) has been dominated by buying, with 2 insider purchases totaling $74.8K and 1 insider sale totaling $731.99. The most recent insider transaction was by NEIS JOHN (Director), who sold $731.99 worth of shares on Dec 12, 2025. Cellectar Biosciences, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $8.8M.

CLRB Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 12, 2025	NEIS JOHN	Director	Sell	198	$3.70	$731.99	0
Jul 2, 2025	CARUSO JAMES V	Chief Executive Officer	Buy	10,000	$4.99	$49.9K	0
Jul 2, 2025	Kolean Chad J	Chief Financial Officer	Buy	5,000	$4.99	$24.9K	0
Jan 10, 2025	Longcor Jarrod	Chief Operating Officer	Buy	30,000	$0.28	$8.4K	0
Sep 14, 2021	Swirsky Douglas J	Director	Buy	25,000	$1.04	$26.0K	25,000
Sep 7, 2021	DRISCOLL FREDERICK W	Director	Buy	19,417	$1.04	$20.2K	19,417
Mar 5, 2021	CARUSO JAMES V	President and CEO	Buy	5,100	$1.70	$8.7K	86,401

CLRB Insider Buying Activity

The following table shows recent insider purchases of Cellectar Biosciences, Inc. (CLRB) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 2, 2025	CARUSO JAMES V	Chief Executive Officer	Buy	10,000	$4.99	$49.9K	0
Jul 2, 2025	Kolean Chad J	Chief Financial Officer	Buy	5,000	$4.99	$24.9K	0
Jan 10, 2025	Longcor Jarrod	Chief Operating Officer	Buy	30,000	$0.28	$8.4K	0
Sep 14, 2021	Swirsky Douglas J	Director	Buy	25,000	$1.04	$26.0K	25,000
Sep 7, 2021	DRISCOLL FREDERICK W	Director	Buy	19,417	$1.04	$20.2K	19,417
Mar 5, 2021	CARUSO JAMES V	President and CEO	Buy	5,100	$1.70	$8.7K	86,401